Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

NCT01427868 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: LB80380 maleate salt
DRUG: LB80380 free base

Sponsor

LG Life Sciences